| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies
|
Shea, Thomas C.
|
|
2003
|
9 |
7 |
p. 443-452
10 p.
|
article
|
| 2 |
ASBMT News
|
|
|
2003
|
9 |
7 |
p. 482-
1 p.
|
article
|
| 3 |
Ed board
|
|
|
2003
|
9 |
7 |
p. A3-
1 p.
|
article
|
| 4 |
Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan
|
Ritchie, David S
|
|
2003
|
9 |
7 |
p. 435-442
8 p.
|
article
|
| 5 |
Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma
|
Pines, Mark
|
|
2003
|
9 |
7 |
p. 417-425
9 p.
|
article
|
| 6 |
Immunologic and hematopoietic effects of recombinant human prolactin after syngeneic bone marrow transplantation in mice
|
Sun, Rui
|
|
2003
|
9 |
7 |
p. 426-434
9 p.
|
article
|
| 7 |
Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation
|
Grosskreutz, Celia
|
|
2003
|
9 |
7 |
p. 453-459
7 p.
|
article
|
| 8 |
Masthead (purpose and scope)
|
|
|
2003
|
9 |
7 |
p. A2-
1 p.
|
article
|
| 9 |
Officers and directors of ASBMT
|
|
|
2003
|
9 |
7 |
p. A4-
1 p.
|
article
|
| 10 |
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation
|
Waller, Edmund K
|
|
2003
|
9 |
7 |
p. 460-471
12 p.
|
article
|
| 11 |
Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia
|
Doney, Kristine
|
|
2003
|
9 |
7 |
p. 472-481
10 p.
|
article
|
| 12 |
Table of contents
|
|
|
2003
|
9 |
7 |
p. A5-
1 p.
|
article
|
Journal description